Molecular determinants of improved cathepsin B inhibition by new cystatins obtained by DNA shuffling

Valadares, Napoleão F.; Dellamano, Márcia; Soares-Costa, Andrea; Henrique-Silva, Flávio; Garratt, Richard C.
January 2010
BMC Structural Biology;2010, Vol. 10, p30
Academic Journal
Background: Cystatins are inhibitors of cysteine proteases. The majority are only weak inhibitors of human cathepsin B, which has been associated with cancer, Alzheimer's disease and arthritis. Results: Starting from the sequences of oryzacystatin-1 and canecystatin-1, a shuffling library was designed and a hybrid clone obtained, which presented higher inhibitory activity towards cathepsin B. This clone presented two unanticipated point mutations as well as an N-terminal deletion. Reversing each point mutation independently or both simultaneously abolishes the inhibitory activity towards cathepsin B. Homology modeling together with experimental studies of the reverse mutants revealed the likely molecular determinants of the improved inhibitory activity to be related to decreased protein stability. Conclusion: A combination of experimental approaches including gene shuffling, enzyme assays and reverse mutation allied to molecular modeling has shed light upon the unexpected inhibitory properties of certain cystatin mutants against Cathepsin B. We conclude that mutations disrupting the hydrophobic core of phytocystatins increase the flexibility of the N-terminus, leading to an increase in inhibitory activity. Such mutations need not affect the inhibitory site directly but may be observed distant from it and manifest their effects via an uncoupling of its three components as a result of increased protein flexibility.


Related Articles

  • Serum cysteine proteases and their inhibitors in rheumatoid arthritis: relation to disease activity and radiographic progression. Jørgensen, Iben; Kos, Janko; Krašovec, Marta; Troelsen, Lone; Klarlund, Mette; Jensen, Trine; Hansen, Michael; Jacobsen, Søren // Clinical Rheumatology;May2011, Vol. 30 Issue 5, p633 

    This study aims to investigate the serum levels of cysteine proteases cathepsins B and H and their inhibitors stefin A, stefin B, and cystatin C, as well as traditional inflammatory markers such as C-reactive protein in patients with rheumatoid arthritis and to correlate these markers with...

  • BACE1 as a Therapeutic Target in Alzheimer's Disease: Rationale and Current Status. Evin, Genevieve; Hince, Christopher // Drugs & Aging;2013, Vol. 30 Issue 10, p755 

    Alzheimer's disease (AD) is a neurodegenerative disease of the central nervous system that causes dementia in a large percentage of the aged population and for which there are only symptomatic treatments. Disease-modifying therapies that are currently being pursued are based on the amyloid...

  • ?-Secretase as a Target for Alzheimer's Disease. Wolfe, Michael S. // Current Topics in Medicinal Chemistry;Apr2002, Vol. 2 Issue 4, p371 

    The amyloid-� peptide (A�) is the major protein component of the characteristic cerebral plaques of Alzheimer's disease (AD), and a large body of evidence supports a pathogenic role for this peptide. Thus, the proteases �- and ?-secretase that are responsible for carving Ab out of...

  • �-Secretase as a Therapeutic Target for Inhibitor Drugs. Ghosh, Arun K.; Lin Hong; Tang, Jordan // Current Medicinal Chemistry;Jun2002, Vol. 9 Issue 11, p1135 

    Recent identification of �-scretasse being a membrane-associated aspartic protease has stimulated strong interest on this enzyme as a therapeutic target for Alzheimer's disease. Here we review the current understanding in the structure-function relationship as well as the status in the...

  • A large and accurate collection of peptidase cleavages in the MEROPS database. Rawlings, Neil D. // Database: The Journal of Biological Databases & Curation;Jan2009, Vol. 2009, p1 

    Peptidases are enzymes that hydrolyse peptide bonds in proteins and peptides. Peptidases are important in pathological conditions such as Alzheimer's disease, tumour and parasite invasion, and for processing viral polyproteins. The MEROPS database is an Internet resource containing information...

  • Identification of BACE2 as an avid β-amyloid-degrading protease. Abdul-Hay, Samer O.; Sahara, Tomoko; McBride, Melinda; Kang, Dongcheul; Leissring, Malcolm A. // Molecular Neurodegeneration;2012, Vol. 7 Issue 1, p46 

    Background: Proteases that degrade the amyloid β-protein (Aβ) have emerged as key players in the etiology and potential treatment of Alzheimer's disease (AD), but it is unlikely that all such proteases have been identified. To discover new Aβ-degrading proteases (AβDPs), we conducted...

  • Characterization of a Flagellar Sheath Component, PF60, and Its Structural Gene in Marine Vibrio1. Furuno, Masaaki; Sato, Ken; Kawagishi, IKuro; Homma, Michio // Journal of Biochemistry;2000, Vol. 127 Issue 1, p29 

    The Polar flagella (Pof) of Vibrio alginolyticus are surrounded by a membrane structure called a sheath. Five major proteins, whose molecular masses are 60, 47, 45, 44, and 18 kDa (named PF60, PF47, PF45, PF44, and PF18, respectively), have been detected in polar flagella. PF47 and PF45 have...

  • A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes. Hamazaki, Jun; Iemura, Shun-ichiro; Natsume, Tohru; Yashiroda, Hideki; Tanaka, Keiji; Murata, Shigeo // EMBO Journal;9/27/2006, Vol. 25 Issue 19, p4524 

    The 26S proteasome is a multisubunit protease responsible for regulated proteolysis in eukaryotic cells. It is composed of one catalytic 20S proteasome and two 19S regulatory particles attached on both ends of 20S proteasomes. Here, we describe the identification of Adrm1 as a novel proteasome...

  • ß-catenin is a target for the ubiquitin-proteasome pathway. Aberle, Herman; Bauer, Andreas; Stappert, Jörg; Kispert, Andreas; Kemler, Rolf // EMBO Journal;7/1/97, Vol. 16 Issue 13, p3797 

    β-catenin is a central component of the cadherin cell adhesion complex and plays an essential role in the Wingless/Wnt signaling pathway. In the current model of this pathway, the amount of β-catenin (or its invertebrate homolog Armadillo) is tightly regulated and its steady-state level...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics